登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Complement Factor D】

Complement Factor D信息

英文名称:Complement factor D
中文名称:补体因子D
靶点别称:EC 3.4.21,EC 3.4.21');,C3 Convertase Activator,ADIPSIN,D Component Of Complement (Adipsin),PFD,Complement Factor D Preproprotein,Complement Factor D (Adipsin),EC 3.4.21.46,ADN,CFD,Properdin factor D,DF,Complement factor D,EC:3.4.21.46
上市药物数量:0
临床药物数量:5
最高研发阶段:临床三期

Complement Factor D产品列表

 
评论(1)
CFD-H52H8|Human Complement Factor D / CFD Protein, His Tag (active enzyme)
  1. 158XXXXXXX8
  2. 0人赞
  3. Acro公司产品质量稳定,相比于国外竞品公司价格更低,性价比更高,已经多次购买! 蛋白包装精美、发货速度快,充足的干冰保证低温运输蛋白不降解,运输到了会当面测温,认真负责。 蛋白纯度很好,质量稳定,用来免疫动物制备抗体,做体外功能试验和亲和力检测,结果都很好很稳定!值得信赖!强烈推荐!
  4. 2023-01-07
 

Complement Factor D 分子别名

CFD,Adipsin,PFD,DF,Complement factor D

Complement Factor D 分子背景

Complement factor D (CFD) is also known as Adipsin, C3 convertase activator, Properdin factor D (PFD), which contains one peptidase S1 domain and belongs to the peptidase S1 family. CFD / Adipsin cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. CFD / Adipsin is a serine protease that stimulates glucose transport for triglyceride accumulation in fats cells and inhibits lipolysis. Defects in CFD / Adipsin are the cause of complement factor D deficiency which predisposes to invasive meningococcal disease.

Complement Factor D 前沿进展

Complement Factor D临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
BCX-9930 BCX-9930 临床二期 Biocryst Pharmaceuticals Inc 阵发性血红蛋白尿症, 免疫球蛋白a肾病, 膜性肾小球肾炎, 肾小球肾炎 详情
ACH-5548 ACH-5548; ACH-0145548 临床一期 Achillion Pharmaceuticals Inc 自身免疫疾病 详情
ALXN-2080 ALXN-2080 临床一期 Alexion Pharmaceuticals Inc 详情
Vemircopan ACH-0145228; ACH-5228; ALXN-2050 临床二期 Achillion Pharmaceuticals Inc 重症肌无力, 免疫球蛋白a肾病, 阵发性血红蛋白尿症, 肾脏疾病, 狼疮肾炎, 肝功能衰退 详情
Danicopan ACH-4471; ACH-0144471; ALXN-2040 临床三期 Achillion Pharmaceuticals Inc 阵发性血红蛋白尿症, 肾功能不全, 新型冠状病毒肺炎, 膜增生性肾小球肾炎, 地图状萎缩, 肝功能衰退, 肾小球肾炎 详情

消息提示

请输入您的联系方式,再点击提交!

确定